PURPOSE: Older adults experience impaired driving performance, and modify their driving habits, including limiting amount and spatial extent of travel. Alzheimer disease (AD)-related pathology, as well as spatial navigation difficulties, may influence driving performance and driving behaviors in clinically normal older adults. We examined whether AD biomarkers [cerebrospinal fluid (CSF) concentrations of Aβ42, tau, and ptau181] were associated with lower self-reported spatial navigation abilities, and whether navigation abilities mediated the relationship of AD biomarkers with driving performance and extent. METHODS: Clinically normal older adults (n=112; aged 65+) completed an on-road driving test, the Santa Barbara Sense of Direction scale (self-report measure of spatial navigation ability), and the Driving Habits Questionnaire for an estimate of driving extent (composite of driving exposure and driving space). All participants had a lumbar puncture to obtain CSF. RESULTS: CSF Aβ42, but not tau or ptau181, was associated with self-reported navigation ability. Lower self-reported navigation was associated with reduced driving extent, but not driving errors. Self-reported navigation mediated the relationship between CSF Aβ42 and driving extent. CONCLUSIONS: Findings suggest that cerebral amyloid deposition is associated with lower perceived ability to navigate the environment, which may lead older adults with AD pathology to limit their driving extent.
PURPOSE: Older adults experience impaired driving performance, and modify their driving habits, including limiting amount and spatial extent of travel. Alzheimer disease (AD)-related pathology, as well as spatial navigation difficulties, may influence driving performance and driving behaviors in clinically normal older adults. We examined whether AD biomarkers [cerebrospinal fluid (CSF) concentrations of Aβ42, tau, and ptau181] were associated with lower self-reported spatial navigation abilities, and whether navigation abilities mediated the relationship of AD biomarkers with driving performance and extent. METHODS: Clinically normal older adults (n=112; aged 65+) completed an on-road driving test, the Santa Barbara Sense of Direction scale (self-report measure of spatial navigation ability), and the Driving Habits Questionnaire for an estimate of driving extent (composite of driving exposure and driving space). All participants had a lumbar puncture to obtain CSF. RESULTS: CSF Aβ42, but not tau or ptau181, was associated with self-reported navigation ability. Lower self-reported navigation was associated with reduced driving extent, but not driving errors. Self-reported navigation mediated the relationship between CSF Aβ42 and driving extent. CONCLUSIONS: Findings suggest that cerebral amyloid deposition is associated with lower perceived ability to navigate the environment, which may lead older adults with AD pathology to limit their driving extent.
Authors: Andrew J Aschenbrenner; David A Balota; Anne M Fagan; Janet M Duchek; Tammie L S Benzinger; John C Morris Journal: J Int Neuropsychol Soc Date: 2015-09 Impact factor: 2.892
Authors: Clifford R Jack; David S Knopman; William J Jagust; Ronald C Petersen; Michael W Weiner; Paul S Aisen; Leslie M Shaw; Prashanthi Vemuri; Heather J Wiste; Stephen D Weigand; Timothy G Lesnick; Vernon S Pankratz; Michael C Donohue; John Q Trojanowski Journal: Lancet Neurol Date: 2013-02 Impact factor: 44.182
Authors: Justin N Chee; Mark J Rapoport; Frank Molnar; Nathan Herrmann; Desmond O'Neill; Richard Marottoli; Sara Mitchell; Mark Tant; Jamie Dow; Debbie Ayotte; Krista L Lanctôt; Regina McFadden; John-Paul Taylor; Paul C Donaghy; Kirsty Olsen; Sherrilene Classen; Yoassry Elzohairy; David B Carr Journal: Am J Geriatr Psychiatry Date: 2017-05-15 Impact factor: 4.105
Authors: Brian R Ott; Elena K Festa; Melissa M Amick; Janet Grace; Jennifer D Davis; William C Heindel Journal: J Geriatr Psychiatry Neurol Date: 2008-03 Impact factor: 2.680
Authors: Lisa Keay; Beatriz Munoz; Kathleen A Turano; Shirin E Hassan; Cynthia A Munro; Donald D Duncan; Kevin Baldwin; Srichand Jasti; Emily W Gower; Sheila K West Journal: Invest Ophthalmol Vis Sci Date: 2008-08-21 Impact factor: 4.799
Authors: Ganesh M Babulal; Cindy M Traub; Mollie Webb; Sarah H Stout; Aaron Addison; David B Carr; Brian R Ott; John C Morris; Catherine M Roe Journal: F1000Res Date: 2016-09-26
Authors: Samantha L Allison; Thomas L Rodebaugh; Chiharu Johnston; Anne M Fagan; John C Morris; Denise Head Journal: Arch Clin Neuropsychol Date: 2019-10-24 Impact factor: 2.813
Authors: Taylor F Levine; Catherine M Roe; Ganesh M Babulal; Anne M Fagan; Denise Head Journal: Alzheimer Dis Assoc Disord Date: 2022 Jan-Mar 01 Impact factor: 2.357
Authors: Xuan Di; Rongye Shi; Carolyn DiGuiseppi; David W Eby; Linda L Hill; Thelma J Mielenz; Lisa J Molnar; David Strogatz; Howard F Andrews; Terry E Goldberg; Barbara H Lang; Minjae Kim; Guohua Li Journal: Geriatrics (Basel) Date: 2021-04-23